# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Sidoti & Co. analyst Anthony Lebiedzinski upgrades Systemax (NYSE:SYX) from Neutral to Buy and announces $44 price target.
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt o...
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 64.9% to $7.75 after the company reported an order for 200,000 sug...
Gainers
Systemax (NYSE:SYX) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.34 by 58.8...
Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per sh...
Friday's morning session saw 420 companies set new 52-week highs.
Gainers GameStop Corp. (NYSE: GME) shares surged 103.9% to close at $91.71 on Wednesday after the stock spiked on heavy volu...